By proceeding, you agree to our Terms of Use and Privacy Policy.
For seven years, the China Healthcare Summit has been building the “Bridge to Innovation” in China.
The 8th BayHelix China Healthcare Summit offers a two-day strategic panel discussion on how China biopharma leaders will influence the global biotech and medtech industries.
The summit includes one-to-one in-person or virtual meetings, exclusive conference reports and 50+ roadshow presentations from global life science companies.
Get inspired and know how Chinese innovators can have a lasting impression on the worldwide biopharma industry!
BioCentury?gives?biopharma executives, investors and institutions the power to make business-critical decisions through independent, deep-dive analysis; high-quality data; and industry-leading business intelligence, and global events.
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.
CBC Group, Asia’s largest healthcare-dedicated investment firm, commits to creating value and integrating global resources.
Exopharm is a clinical-stage biopharmaceutical company using exosomes to deliver a new class of transformative medicines and generate revenue from multiple partnership deals.
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.
LYZZ Capital is a leading global healthcare-dedicated VC/PE firm. We currently are actively investing out of USD and RMB funds totaling over USD$460 million.
Lake Bleu Capital is a Hong Kong-based asset management company that specializes in healthcare investing in Asia, with a primary focus on Greater China.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.